Lamotrigin Beta

Lamotrigine, the active ingredient in Lamotrigin Beta, is an anticonvulsant presented as an oral tablet for oral use. It treats epilepsy and bipolar disorder in adults and adolescents, helping to control seizures and stabilize mood by modulating neuronal excitability and reducing excitatory neurotransmitter release.

GNH USA supplies Lamotrigin Beta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets.

Lamotrigine is used in the management of seizure disorders and mood stabilization, targeting neuronal hyperexcitability. - Epilepsy (partial seizures): Reduces the frequency and severity of seizure episodes. - Generalized seizures: Helps control tonic‑clonic and other generalized seizure types. - Bipolar disorder (maintenance therapy): Stabilizes mood and lowers the risk of depressive relapse.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: Transient light‑headedness, especially at treatment initiation. - Headache: Mild to moderate intensity, often improves with continued therapy. - Nausea: Gastrointestinal upset that may lessen over time. - Rash: Skin irritation or mild maculopapular eruptions. - Blurred vision: Temporary visual disturbances. - Insomnia: Difficulty falling or staying asleep.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: Severe skin reaction requiring immediate medical attention. - Aseptic meningitis: Inflammation of the meninges without infection. - Blood dyscrasias: Rare cases of agranulocytosis or aplastic anemia. - Hepatic failure: Severe liver injury in isolated reports. - Suicidal thoughts: Emergence or worsening of depressive symptoms.

When prescribing lamotrigine, clinicians should consider several safety precautions to minimize risk. - Skin monitoring: Observe for rash or signs of Stevens‑Johnson syndrome. - Liver function: Check hepatic enzymes periodically, especially in patients with pre‑existing liver disease. - Discontinuation: Avoid abrupt cessation to prevent seizure recurrence. - Concomitant drugs: Adjust dose when used with enzyme‑inducing antiepileptics such as carbamazepine. - Pregnancy: Evaluate risk‑benefit as data are limited; discuss with the patient. - Store at room temperature: Keep in the original container, protect from moisture.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase toxicity.

Major Interactions (Avoid): - Valproate: Increases lamotrigine levels, raising risk of toxicity. - Carbamazepine: Decreases lamotrigine levels, potentially reducing efficacy. - Phenobarbital: Lowers lamotrigine concentrations, may require dose increase. - Phenytoin: Reduces lamotrigine exposure, risking sub‑therapeutic effect. - Oral contraceptives: Elevate lamotrigine levels, may necessitate dose adjustment.

Moderate Interactions (Monitor Closely): - Serotonergic agents: Monitor for signs of serotonin syndrome. - Other antiepileptics: May require individualized dosing based on therapeutic response. - Antidepressants: Observe for mood changes or increased suicidality.